Cresset Asset Management, LLC Iovance Biotherapeutics, Inc. Transaction History

Cresset Asset Management, LLC

$19.6 Billion
Q2 2025

A detailed history of Cresset Asset Management, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Cresset Asset Management, LLC holds 189,273 shares of IOVA stock, worth $435,327. This represents 0.0% of its overall portfolio holdings.

Number of Shares

189,273

Previous 78,273 141.81%

Holding current value

$435,327

Previous $260,000 25.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$1.66 - $3.61 $184,260 - $400,710	111,000 Added 141.81%	189,273 $325,000
Q1 2025 May 13, 2025	SELL	$3.33 - $7.79 $96 - $225	-29 Reduced 0.04%	78,273 $260,000
Q4 2024 Feb 14, 2025	SELL	$7.17 - $12.28 $17,975 - $30,785	-2,507 Reduced 3.1%	78,302 $579,000
Q3 2024 Nov 14, 2024	BUY	$7.28 - $11.9 $6,304 - $10,305	866 Added 1.08%	80,809 $758,000
Q2 2024 Aug 14, 2024	BUY	$7.78 - $14.19 $69,374 - $126,532	8,917 Added 12.55%	79,943 $641,000
Q1 2024 May 15, 2024	SELL	$7.59 - $17.47 $43,369 - $99,823	-5,714 Reduced 7.45%	71,026 $1.05 Million
Q4 2023 Feb 14, 2024	BUY	$3.3 - $8.89 $102,867 - $277,119	31,172 Added 68.41%	76,740 $623,000
Q3 2023 Nov 14, 2023	BUY	$4.44 - $8.79 $58,945 - $116,696	13,276 Added 41.11%	45,568 $207,000
Q2 2023 Aug 14, 2023	BUY	$5.36 - $9.06 $6,925 - $11,705	1,292 Added 4.17%	32,292 $227,000
Q4 2022 Feb 14, 2023	SELL	$5.62 - $10.0 $78,680 - $140,000	-14,000 Reduced 31.11%	31,000 $198,000
Q3 2022 Nov 14, 2022	BUY	$9.53 - $13.11 $199,825 - $274,890	20,968 Added 87.25%	45,000 $431,000
Q2 2022 Aug 15, 2022	SELL	$6.38 - $18.33 $30,381 - $87,287	-4,762 Reduced 16.54%	24,032 $265,000
Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $116,458 - $179,673	9,407 Added 48.52%	28,794 $479,000
Q4 2021 Feb 10, 2022	BUY	$16.55 - $27.63 $8,192 - $13,676	495 Added 2.62%	19,387 $369,000
Q3 2021 Nov 15, 2021	SELL	$20.35 - $26.63 $84,940 - $111,153	-4,174 Reduced 18.1%	18,892 $466,000
Q2 2021 Aug 10, 2021	BUY	$16.33 - $33.07 $204,631 - $414,400	12,531 Added 118.95%	23,066 $600,000
Q1 2021 May 12, 2021	BUY	$28.67 - $52.59 $302,038 - $554,035	10,535 New	10,535 $333,000

Others Institutions Holding IOVA

# of Institutions

292

Shares Held

231M

Call Options Held

1.14M

Put Options Held

1.15M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $363M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.

Account

Cresset Asset Management, LLC Iovance Biotherapeutics, Inc. Transaction History